Alfred Lloyd Bowie Jr.
CIK: 0002104152
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EIKN
Eikon Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Bowie Alfred Lloyd Jr.
Bowie Alfred Lloyd Jr. (SEC CIK 0002104152) files insider reports with the SEC as Chief Financial Officer of Eikon Therapeutics, Inc. (EIKN).
Signal8 holds 2 ownership filings by Bowie Alfred Lloyd Jr. (1 Form 3, 1 Form 4), filed between Feb 4, 2026 and Mar 4, 2026. Those filings report 1 transaction, the latest on Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bowie Alfred Lloyd Jr.'s filings is in MILLBRAE, CA.
Recent filings by Bowie Alfred Lloyd Jr.
- Mar 2, 2026: Grant or award of EIKN derivative securities (Form 4, code A).
Other insiders filing for Eikon Therapeutics, Inc. (EIKN)
- Column Group IV GP, LP, 10% Owner
- Francisco Ma. Fatima, Director
- Klobuchar Michael A, Chief Operating Officer
- Huffines Robert Luther, Director
- FRAZIER KENNETH C, Director
- PERLMUTTER ROGER M